Candidate Drug 80/5Technology Demonstration4 (Anti-dyslipidemic) | India Science, Technology & Innovation - ISTI Portal

×

Acces sibility Controls

Candidate Drug 80/5Technology Demonstration4 (Anti-dyslipidemic)

Implementing Organization

Central Research Institute (CRI)

Central Drug Research Institute (CDRI)

About

Anti-Dyslipidemic drug especially used in Dyslipidemia of Diabetes, Metabolic syndrome Obesity For managing patients of hyperlipidemia especially triglycerides and cholesterol

Patent Details

EP1020191, IN193304, US65Technology Demonstration9862, US68Technology Demonstration5Technology Demonstration58

Related Research

Quick Information

Area of Research

Life Sciences & Biotechnology

Focus Area

Hyperlipidemia Treatment

Status

completed

Patent No.

EP1020191, IN193304, US65Technology Demonstration9862, US68Technology Demonstration5Technology Demonstration58

Output in Numbers

Research Paper

00

Technologies (If Any)

00

PhD Produced

N/A

Startup (If Any)

00

Patents

Filed :01

Grant :00